COVID Testing Kits
Cayman Chemical SARSCoV2 SpIke GlycoproteIn
A BD2 bromodomain inhibitor inhibits BD2 in BRD2 BRD3 BRD4 and BRDT (IC50s 264 98 49 and 214 nM respectively) and is selective for BD2 over BD1 (IC50s 10.96 36.31 70.55 and 50.11 UM for BRD2 BRD3 BRD4 and BDT respectively) in a TR-FRET assay inhibits IFN-Y-induced protein expression of MHC class I in K562 cells at 1 UM reduces the production of anti-KLH IgM antibodies in mice immunized with KLH at 40 mg/kg
Innovative Research Inc Single Donor Human SARS-Cov-2 Negative Serum 100ul
Single Donor Human SARS-Cov-2 Negative Serum from Innovative Research is a whole blood derived product. Samples were collected from presumptive negative donors prior to December 2019, and COVID-19 negative status has been confirmed via SARS-CoV-2 IgG antibody assay. This serum is suitable for use as a negative control and to confirm serological assay results, among other research applications. This product has not been tested directly for the presence of any other viruses, and out of an abundance of caution it is recommended to handle as if capable of spreading infectious disease.
Sino Biological SARS-CoV-2 (KP.3.1.1) Spike S1+S2 trimer Protein (ECD, His tag)(MALS-verified)
A DNA sequence encoding the SARS-CoV-2 (KP.3.1.1) Spike S1+S2 (YP_009724390.1, with mutations ins16MPLF, T19I, R21T, L24S, del25/27, del31/31, S50L, del69/70, V127F, G142D, del144/144, F157S, R158G, N211I, del212/212, V213G, L216F, H245N, A264D, I332V, G339H, K356T, S371F, S373P, S375F, T376A, R403K, D405N, R408S, K417N, N440K, V445H, G446S, N450D, L452W, L455S, F456L, N460K, S477N, T478K, N481K, del483/483, E484K, F486P, Q493E, Q498R, N501Y, Y505H, E554K, A570V, D614G, P621S, H655Y, N679K, P681R, R682G, R683S, R685S, N764K, D796Y, F817P, A892P, A899P, S939F, A942P, Q954H, N969K, K986P, V987P, V1104L, P1143L and furin cleavage site mutants) expressed with the bacteriophage T4 fibritin and a polyhistidine tag at the C-terminus. The mutations were identified in the SARS-CoV-2 variant (known as variant KP.3.1.1).
Creative Biomart Recombinant Influenza B virus B/Massachusetts/2/2012 BX-51B Hemagglutinin Antigen (formaldehyde inactivated)
A seasonally-specific component of the influenza vaccine. The influenza vaccine, also known as the "flu shot", is a vaccine that protects against infection from the influenza viruses. Vaccines provide
HCL Labels Social Distancing Floor Sign (Spanish) - Protect yourself and others! KEEP DISTANCE Stand here! (Spanish) - 12" x 12" Adhesive Floor Sign
Social Distancing Floor Sign (Spanish) - Protect yourself and others! KEEP DISTANCE Stand here! (Spanish) - 12" x 12" Adhesive Floor Sign
Cayman Chemical SARSCoV2 SpIke GlycoproteIn
An ENPP1 inhibitor inhibits the hydrolysis of 23-cGAMP and AMP-pNP (Kis ≤100 and 100-1000 nM respectively in enzyme assays) enhances transcription of the gene encoding IFN-B in 23-cGAMP-stimulated HFF-1 cells
Cayman Chemical SARS-CoV-2 nsp1recombInt 100ug
Source: Recombinant SARS-CoV-2 N-Terminal His-tagged nsp1 expressed in E. coli • Amino acids: 13-128
Meso Scale Discovery R-PLEX SARS-CoV-2 Spike ASYQP
The R-PLEX SARS-CoV-2 Spike Assay is a multiplex immunoassay panel that detects antibodies to the SARS-CoV-2 spike protein in human serum and plasma It uses Meso Scale Discovery electrochemiluminescence technology and provides quantitative results for IgG IgM and IgA antibodies The assay has high sensitivity and specificity and is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2 indicating recent or prior infection It requires a small sample volume and provides results in under 3 hours The kit includes a 96-well plate calibrators controls diluent and substrate
Cayman Chemical SARS-CoV-2 nsp1recombInt 500ug
Source: Recombinant SARS-CoV-2 N-Terminal His-tagged nsp1 expressed in E. coli • Amino acids: 13-128
Cayman Chemical SARS-CoV-2 nutralIzng ntIb 1ea
A set of SARS-CoV-2 neutralizing antibody human serum controls containing negative control serum, as well as positive control serum spiked with low, mid, and high levels of recombinant human anti-SARS-CoV-2 neutralizing IgG antibody